The conference focuses on latest developments in tackling antimicrobial resistance (AMR) in England. It comes with the 2013-2018 UK AMR Strategy due to complete soon and with AMR cited by the Minister for Public Health as central to the forthcoming NHS Long-Term Plan, which is set to focus on prevention, funding and research.
With a refreshed AMR strategy expected to include a 20-year vision and 5-year action plans, the agenda looks at the way forward for delivery to ensure that key aims are met.
Ask for a Free trial and get access to our last stories
- Health Care
- Market Access
- HTA – policies & practices
- European medicine regulations
- Drug safety issues
- Pricing & Reimbursement
- International medicines agencies
If you are a Payer, Pharmaceutical or Consulting professional our premium data will keep you informed on the regulatory, pricing, market access and cost-effectiveness issues that impact all stakeholders.
an initial 10 day temporary access of APM Health Europe.